These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 15918159)
1. Guidelines for good pharmacoepidemiology practices (GPP). Epstein M; Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):589-95. PubMed ID: 15918159 [No Abstract] [Full Text] [Related]
2. Guidelines for good pharmacoepidemiology practices (GPP). ISPE Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):200-8. PubMed ID: 17868186 [No Abstract] [Full Text] [Related]
3. Guidelines for good pharmacoepidemiology practice (GPP). Public Policy Committee, International Society of Pharmacoepidemiology Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):2-10. PubMed ID: 26537534 [No Abstract] [Full Text] [Related]
4. Quantitative signal detection using spontaneous ADR reporting. Bate A; Evans SJ Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225 [TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making. Etminan M; Gill S; Fitzgerald M; Samii A J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278 [TBL] [Abstract][Full Text] [Related]
6. Data mining for signals in spontaneous reporting databases: proceed with caution. Stephenson WP; Hauben M Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):359-65. PubMed ID: 17019675 [TBL] [Abstract][Full Text] [Related]
7. The case-crossover and case-time-control designs in pharmacoepidemiology. Donnan PT; Wang J Pharmacoepidemiol Drug Saf; 2001 May; 10(3):259-62. PubMed ID: 11501340 [No Abstract] [Full Text] [Related]
8. The need for standards, not guidelines, in biological data reporting and sharing. Burgoon LD Nat Biotechnol; 2006 Nov; 24(11):1369-73. PubMed ID: 17093486 [TBL] [Abstract][Full Text] [Related]
9. Reports of hyperkalemia after publication of RALES--a pharmacovigilance study. Hauben M; Reich L; Gerrits CM Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):775-83. PubMed ID: 16804951 [TBL] [Abstract][Full Text] [Related]
10. How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed? Alla F; Rosilio M; Funck-Brentano C; ; Barthélémy P; Brisset S; Cellier D; Chassany O; Demarez JP; Diebolt V; Francillon A; Gambotti L; Hannachi H; Lechat P; Lemaire F; Lièvre M; Misse C; Nguon M; Pariente A; Rosenheim M; Weisslinger-Darmon N Therapie; 2013; 68(4):209-23. PubMed ID: 23981258 [TBL] [Abstract][Full Text] [Related]
11. The International Society of Pharmacovigilance. Edwards R Pharmacoepidemiol Drug Saf; 2002; 11(3):253-4. PubMed ID: 12051125 [No Abstract] [Full Text] [Related]
12. An analysis of the exclusion criteria used in observational pharmacoepidemiological studies. Perrio M; Waller PC; Shakir SA Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):329-36. PubMed ID: 16741894 [TBL] [Abstract][Full Text] [Related]
14. Data mining in spontaneous reports. Bate A; Edwards IR Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):324-30. PubMed ID: 16611210 [TBL] [Abstract][Full Text] [Related]
15. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Olivier P; Montastruc JL Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082 [TBL] [Abstract][Full Text] [Related]
16. European commission consultation on pharmacovigilance. Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839 [No Abstract] [Full Text] [Related]
17. Did thirst-blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave? Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):312-3. PubMed ID: 18300324 [No Abstract] [Full Text] [Related]
18. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Wise RP; Bonhoeffer J; Beeler J; Donato H; Downie P; Matthews D; Pool V; Riise-Bergsaker M; Tapiainen T; Varricchio F; Vaccine; 2007 Aug; 25(31):5717-24. PubMed ID: 17493712 [No Abstract] [Full Text] [Related]
19. Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Kohl KS; Ball L; Gidudu J; Hammer SJ; Halperin S; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2007 Aug; 25(31):5821-38. PubMed ID: 17540485 [No Abstract] [Full Text] [Related]
20. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Rüggeberg JU; Gold MS; Bayas JM; Blum MD; Bonhoeffer J; Friedlander S; de Souza Brito G; Heininger U; Imoukhuede B; Khamesipour A; Erlewyn-Lajeunesse M; Martin S; Mäkelä M; Nell P; Pool V; Simpson N; Vaccine; 2007 Aug; 25(31):5675-84. PubMed ID: 17448577 [No Abstract] [Full Text] [Related] [Next] [New Search]